Venture café Special Event: Innovation Bridge Tokyo – Rotterdam: Life Sciences & Health

Innovation Bridge is a series of events to bridge between cities to facilitate collaboration and make things happen. Venture Café Tokyo and Rotterdam collaborate to bridge between two countries and share each other’s Life Science & Health ecosystems and forefront of innovation in the area.

The Netherlands is one of the happiest countries in the world, but it is also one of the best in Europe and a world leader in Life Science & Health innovation! The Netherlands is home to more than 3,100 innovative Life Science & Health companies, which work together in public-private partnerships with academia, business and government to create an innovation ecosystem. With a concentration of life science companies within a 200 km radius, including major multinationals such as Janssen, Amgen, Astellas, and GlaxoSmithKline, the Netherlands has one of the highest concentrations of life science industries in the world (Ref: Invest in Holland).

In this event, Venture Café shares “Frontline of innovation in Life Science & Health” from both sides and discuss “How Japan and Netherlands can collaborate to create a future in which all people can live in good health”. They also have a pitch session to showcase our wonderful life science & health startups!

Venture Café focusses on CONNECTION at the Innovation Bridge by bringing key players along and taking actions to build a connection with them to make things happen. Let’s CONNECT with speakers, startups and investors at the virtual networking space and expand your network to Rotterdam!

This Innovation Bridge program replaces Venture Café Rotterdam’s LSH010 Café which is organized on a monthly basis together with our partners: Gemeente Rotterdam, InnovationQuarter, Rotterdam Partners and Erasmus MC. We have all bundled our powers to ensure a great line up for this international event full of connections and opportunities.

Program

12:00-12:45 – Panel Discussion: How Japan and Netherlands can collaborate to foster Life Science & Health Innovation!

12:45-13:00 – Networking with Panelists

13:00 – 14:00 –  Life Science & Health Startups Pitch + Networking

Panelists

Venture Café Rotterdam
Venture Café Tokyo
  • Dr. Tord Labuda / Vice President of R&D, Asia-Pacific at LEO Pharma
  • Dr. Olivier Van Till / Senior Medical Director at Astellas Pharma

Life Science & Health Startups Pitches

Pitches from Tokyo:
Pitches from Rotterdam:
  • Varsha Thakoersing / Business Developer at IMcoMET
    IMcoMET is a MedTech start-up that has developed its patented M-Duo Technology – a technology that allows you to continuously extract, sample, and control the composition of the microenvironment with high spatial precision. The M-Duo technology is originally developed for IMcoMET’s main goal, namely treatment of skin cancer patients. But it can also be a game changer for other applications. This is particularly true for diagnostic applications based on extraction of biomarkers from skin interstitial fluid, and R&D activities involving in vitro 3D cell cultures (organoids, tumoroids, organ on a chip), and ex vivo tissue biopsies.
  • Julian Jagtenberg / Founder at Somnox
    Sleep deprivation is a growing problem that impacts millions of people across the world. Current treatments often include pharmaceuticals which can have harmful side-effects and are potentially addictive. At Somnox we are motivated to help you improve your sleep in a more natural way, and believe everyone should be able to experience the superpower of sleep. We developed a Sleep Robot. Our technology is soft, companion-like and easy to use, and therefore helps you to not only fall asleep more naturally, but also help you experience more comfort and rest.
  • Katrien Reynders-Frederix / CEO at Pan Cancer T
    Pan Cancer T is a biotechnology spin-out from Erasmus MC, Rotterdam, the Netherlands dedicated to discovering and developing T cell receptor (TCR) T cell therapies. The company exploits 20 years of pioneering research in the field of adoptive T cell therapies. This foundation serves as a springboard towards breakthrough therapies for solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies against unique and proprietary intracellular targets expressed by multiple solid tumors.
  • Willem Mees van der Bijl / Director IDE Netherlands at IDE Group
    IDE is a group of like minded people and organisations, that love working together to utilise design, engineering and entrepreneurial capabilities. We create meaningful change, improve lives, start and grow new organisations, to build better futures.
  • Motoaki Komiya / Managing Director at Cyberdyne Care Robotics GmbH
    Cyberdyne envisions a future where humans and technology are seamlessly interfaced, feeding off of each other in both cyberspace and physical space to revolutionize the way society functions and improve the lives of its citizens. In medical applications, all of our Medical Cybernic Systems are intended to reconstruct the neural connectivity network (including the connectome of the brain) and improve/regenerate the patient’s brain-neuro-physical function by promoting the improvement/strengthening of synaptic connections between the brain, nerves, and muscles.

Networking with startups, investors, and participants

In between the above scheduled sessions there is time to network and engage (12-2pm CEST). The panel members and pitching startups will be present, but you can surely expect other interesting community members to join, including:

Venture Café Rotterdam 
Investors/Corporate/Community/Startup Supporters
Venture Café Tokyo
Investors/Corporate/Community/Startup Supporters

About Venture Café Rotterdam

Venture Café is thé place in Rotterdam where startups, corporates, talent, government and investors are connected to stimulate innovation and growth.

Register here for the Special Event: Innovation Bridge Tokyo – Rotterdam: Life Sciences & Health!

Datum: 6 mei 2021
Locatie: Online
Tijd: 12:00 - 14:00